PreprintCited by 1,245Cancer-related Molecular PathwaysTelomeres, Telomerase, and SenescenceCell death mechanisms and regulation

The DOI matches its Crossref record; 54 of the 60 references it cites were found in a registry or an index.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Open access

Zindy, Frederique, Eischen, Christine M., Randle, David H., Kamijo, Takehiko, Cleveland, John L., Sherr, Charles J., Roussel, Martine F.·1998·Genes & Development

DOI 10.1101/gad.12.15.2424PMC PMC317045

Open this paper in CoChat — free account Open PDF

Abstract

Establishment of primary mouse embryo fibroblasts (MEFs) as continuously growing cell lines is normally accompanied by loss of the p53 or p19(ARF) tumor suppressors, which act in a common biochemical pathway. myc rapidly activates ARF and p53 gene expression in primary MEFs and triggers replicative crisis by inducing apoptosis. MEFs that survive myc overexpression sustain p53 mutation or ARF loss during the process of establishment and become immortal. MEFs lacking ARF or p53 exhibit an attenuated apoptotic response to myc ab initio and rapidly give rise to cell lines that proliferate in chemically defined medium lacking serum. Therefore, ARF regulates a p53-dependent checkpoint that safeguards cells against hyperproliferative, oncogenic signals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.12.15.2424

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“Expression of activated ras in primary MEFs inhibits cell growth (Serrano et al. 1997), whereas overexpression of myc in these same cells triggers apoptosis, a process further aggravated by withdrawal of serum survival factors (Evan et al. 1992).”
Background
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“In turn, Mdm2 acts in a feedback loop to catalyze p53 ubiquitination and degrada- tion, limiting the p53 response (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).”
Background
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Show all 60 references

Research works printed but not linked: 1

10.1126/science.256.5058.827 · DOI

Sorted by citations

Items 501–600 of 1,001

BRCA1 signals ARF-dependent stabilization and coactivation of p53
Somasundaram, K., MacLachlan, T. K., Burns, T. F., Sgagias, M. K., Cowan, K. H., Weber, B. L., & El‐Deiry, W. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203284 · Cited by 66
Rac1 GTPase Regulates Cell Genomic Stability and Senescence
Debidda, M., Williams, D. A., & Zheng, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604607200 · Cited by 69
BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis
Patel, J. H., & McMahon, S. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609138200 · Cited by 68
MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications
Sewastianik, T., Prochorec‐Sobieszek, M., Chapuy, B., & Juszczyński, P. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.006 · Cited by 65
Isolation and Characterization of a Novel Pituitary Tumor Apoptosis Gene
Bahar, A., Simpson, D. J. W., Cutty, S. J., Bicknell, J., Hoban, P. R., Holley, S. L., Mourtada‐Maarabouni, M., Williams, G. T., Clayton, R. N., & Farrell, W. E. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0087 · Cited by 64
Association of p14ARF with the p120E4FTranscriptional Repressor Enhances Cell Cycle Inhibition
Rizos, H., Diefenbach, E., Badhwar, P., Woodruff, S., Becker, T. M., Rooney, R. J., & Kefford, R. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210978200 · Cited by 64
Absence of p16 INK4a and truncation of ARF tumor suppressors in chickens
Kim, S.-H., Mitchell, M., Fujii, H., Llanos, S., & Peters, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0135557100 · Cited by 63
Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non–Small Cell Lung Cancer Cells
Chien, W., Yin, D., Gui, D., Mori, A., Frank, J. M., SAID, J. W., Kusuanco, D. A., Marchevsky, A. M., McKenna, R. J., & Koeffler, H. P. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0029 · Cited by 66
p73 in apoptosis
Stiewe, T., & Pützer, B. M. (2001) · APOPTOSIS · doi:10.1023/a:1012433522902 · Cited by 63
Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases
Hotti, A., Järvinen, K., Siivola, P., & Hölttä, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203567 · Cited by 63
ARF Is Not Required for Apoptosis in Rb Mutant Mouse Embryos
Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Crowley, D. G., & Jacks, T. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00659-5 · Cited by 63
Oncogenes and senescence: breaking down in the fast lanePreprint
Hemann, M. T., & Narita, M. (2007) · Genes & Development · doi:10.1101/gad.1514207 · Cited by 66
Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
Zhao, Y., Huang, Z., & Peng, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.743006 · Cited by 62
The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy
Udayakumar, T. S., Shareef, M. M., Diaz, D. A., Ahmed, M. M., & Pollack, A. S. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.007 · Cited by 62
Inactivation of MYC reverses tumorigenesis
Li, Y., Casey, S. C., & Felsher, D. W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12237 · Cited by 64
The Multiple Facets of PRC2 Alterations in Cancers
Wassef, M. A., & Margueron, R. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.10.012 · Cited by 72
Parsing Ink4a/Arf
Sherr, C. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00486-x · Cited by 62
Self-citation
Essential Role of the B23/NPM Core Domain in Regulating ARF Binding and B23 Stability
Enomoto, T., Lindström, M. S., Jin, A., Ke, H., & Zhang, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602788200 · Cited by 62
p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways
Sánchez‐Aguilera, A., Sánchez‐Beato, M., García, J. F., Priéto, I., Pollán, M., & Piris, M. A. (2002) · Blood · doi:10.1182/blood.v99.4.1411 · Cited by 62
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
Traweek, R. S., Cope, B. M., Roland, C. L., Keung, E. Z.-Y., Nassif, E. F., & Erstad, D. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1006959 · Cited by 64
c-Myc and Caspase-2 Are Involved in Activating Bax during Cytotoxic Drug-induced Apoptosis
Cao, X., Bennett, R. L., & May, W. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801107200 · Cited by 61
SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
Mallette, F. A., Calabrese, V., Ilangumaran, S., & Ferbeyre, G. (2010) · Aging · doi:10.18632/aging.100163 · Cited by 62
Chemotherapy response and resistance
Lee, S., & Schmitt, C. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00014-x · Cited by 61
c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
Ceballos, E., Delgado, M. D., Gutierrez, P., Richard, C., Müller, D., Eilers, M., Ehinger, M., Gullberg, U., & León, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203541 · Cited by 61
ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
Wang, Y., Godin-Heymann, N., WANG, X.-D., Bergamaschi, D., Llanos, S., & Lü, X. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.3 · Cited by 60
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation
Reddy, J. P., Peddibhotla, S., Bu, W., Zhao, J., Haricharan, S., Du, Y. N., Podsypanina, K., Rosen, J. M., Donehower, L. A., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910665107 · Cited by 60
Cell-cycle dysregulation in breast cancer: breast cancer therapies targeting the cell cycle
Brian, T. Z. (2000) · Frontiers in bioscience · doi:10.2741/zafonte · Cited by 61
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
Wirth, M., Stojanovic, N., Christian, J. G., Paul, M. C., Stauber, R. H., Schmid, R. M., Häcker, G. A., Krämer, O. H., Saur, D., & Schneider, G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku763 · Cited by 62
Control of Cell Proliferation by Myc Family Genes
Eilers, M. (1999) · Molecules and Cells · doi:10.1016/s1016-8478(23)13499-6 · Cited by 60
Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang, Y., Zhang, Z., Kastens, E., Lubet, R. A., & You, M. (2003) · PubMed · Cited by 60
MYC Cofactors: Molecular Switches Controlling Diverse Biological OutcomesPreprint
Hann, S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014399 · Cited by 60
STAT3 can serve as a hit in the process of malignant transformation of primary cells
Demaria, M., Misale, S., Giorgi, C., Miano, V., Camporeale, A., Campisi, J., Pinton, P., & Poli, V. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.20 · Cited by 60
ARF and p53 Coordinate Tumor Suppression of an Oncogenic IFN-β-STAT1-ISG15 Signaling Axis
Forys, J. T., Kuzmicki, C. E., Saporita, A. J., Winkeler, C. L., Maggi, L. B., & Weber, J. D. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.026 · Cited by 61
DNA Damage–Dependent Translocation of B23 and p19ARF Is Regulated by the Jun N-Terminal Kinase Pathway
Yogev, O., Saadon, K., Anzi, S., Inoue, K., & Shaulian, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2865 · Cited by 59
Polyamine-modulated c-Myc expression in normal intestinal epithelial cells regulates p21Cip1 transcription through a proximal promoter region
Liu, L., Guo, X., Rao, J. N., Zou, T., Marasa, B. S., Chen, J., Greenspon, J., Casero, R. A., & Wang, J. (2006) · Biochemical Journal · doi:10.1042/bj20060217 · Cited by 59
p400 Is Required for E1A to Promote Apoptosis
Samuelson, A. V., Narita, M., Chan, H., Jin, J., de Stanchina, E., McCurrach, M. E., Narita, M., Fuchs, M., Livingston, D. M., & Lowe, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414564200 · Cited by 61
Inactivation of the ARF–MDM-2–p53 pathway in sporadic Burkitt's lymphoma in children
Wilda, M., Bruch, J., Harder, L., Rawer, D., Reiter, A., Borkhardt, A., & Woessmann, W. (2003) · Leukemia · doi:10.1038/sj.leu.2403254 · Cited by 59
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar, S., Jülicher, K., Burger, M. S., Della-Valle, V., Larsen, C., Yeager, T. R., Grossman, T. B., Nickells, R. W., Protzel, C., Jarrard, D. F., et al. (2000) · PubMed · Cited by 58
Cystatins and cancer
James, L. C. (2009) · Frontiers in bioscience · doi:10.2741/3255 · Cited by 59
Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik
Lopez, J., Hesling, C., Prudent, J., Popgeorgiev, N., Gadet, R., Mikaélian, I., Rimokh, R., Gillet, G., & Gonzalo, P. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.21 · Cited by 60
MicroRNA (miRNA)-mediated Interaction between Leukemia/Lymphoma-related Factor (LRF) and Alternative Splicing Factor/Splicing Factor 2 (ASF/SF2) Affects Mouse Embryonic Fibroblast Senescence and Apoptosis
Verduci, L., Simili, M., Rizzo, M., Mercatanti, A., Evangelista, M., Mariani, L., Rainaldi, G., & Pitto, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114736 · Cited by 58
Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein
Eichten, A., Westfall, M. D., Pietenpol, J. A., & Münger, K. (2002) · Virology · doi:10.1006/viro.2002.1375 · Cited by 58
Cellular signaling in normal and cancerous stem cells
Grinstein, E., & Wernet, P. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.06.021 · Cited by 58
A porcine model of osteosarcoma
Saalfrank, A., Janssen, K., Ravon, M., Flisikowski, K., Eser, S., Steiger, K., Flisikowska, T., Müller-Fliedner, P., Schulze, É. A., Brönner, C., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.19 · Cited by 58
The Human Tumor Suppressor ARF Interacts with Spinophilin/Neurabin II, a Type 1 Protein-phosphatase-binding Protein
Vivo, M., Calogero, R., Sansone, F., Calabrò, V., Parisi, T., Borrelli, L., Saviozzi, S., & Mantia, G. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006845200 · Cited by 57
Involvement of Rho Family GTPases in p19Arf- and p53-Mediated Proliferation of Primary Mouse Embryonic Fibroblasts
Guo, F., & Zheng, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1426-1438.2004 · Cited by 57
Transcriptional Regulation of the Human Tumor Suppressor p14ARF by E2F1, E2F2, E2F3, and Sp1-like Factors
Parisi, T., Pollice, A., Cristofano, A. D., Calabrò, V., & Mantia, G. L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6591 · Cited by 57
Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
Fish, K., Chen, J., & Longnecker, R. (2013) · Blood · doi:10.1182/blood-2013-07-517649 · Cited by 56
Prostatic preneoplasia and beyond
Joshua, A. M., Evans, A., van der Kwast, T., Zieleńska, M., Meeker, A. K., Chinnaiyan, A. M., & Squire, J. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.12.001 · Cited by 62
Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancersPreprint
Symer, D. E., Akagi, K., Geiger, H. M., Yang, S. T., Li, G., Emde, A., Xiao, W., Jiang, B., Corvelo, A., Toussaint, N. C., et al. (2021) · Genome Research · doi:10.1101/gr.275911.121 · Cited by 58
Acute Overexpression of Myc in Intestinal Epithelium Recapitulates Some but Not All the Changes Elicited by Wnt/β-Catenin Pathway Activation
Finch, A. J., Soucek, L., Junttila, M. R., Swigart, L. B., & Evan, G. I. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01745-08 · Cited by 55
c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells
Faumont, N., Durand-Panteix, S., Schlee, M., Grömminger, S., Schuhmacher, M., Hölzel, M., Laux, G., Mailhammer, R., Rosenwald, A., Staudt, L. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02264-08 · Cited by 55
p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell
Tessoulin, B., Eveillard, M., Lok, A., Chiron, D., Moreau, P., Amiot, M., Moreau‐Aubry, A., Gouill, S. L., & Pellat‐Deceunynck, C. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.03.001 · Cited by 55
Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences
Feldmeyer, N., Schmeiser, H. H., Muehlbauer, K., Belharazem, D., Knyazev, Y. P., Nedelko, T., & Hollstein, M. C. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.02.017 · Cited by 55
Targeted Deletion of the S-Phase-Specific Myc Antagonist Mad3 Sensitizes Neuronal and Lymphoid Cells to Radiation-Induced Apoptosis
Quéva, C., McArthur, G. A., Iritani, B. M., & Eisenman, R. N. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.703-712.2001 · Cited by 55
Animal Models of Tumor-Suppressor Genes
Hakem, R., & Mak, T. W. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090432 · Cited by 57
MYC and the Art of MicroRNA MaintenancePreprint
Psathas, J. N., & Thomas‐Tikhonenko, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014175 · Cited by 55
A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2
Wang, J., He, X., Luo, Y., & Yarbrough, W. G. (2005) · Biochemical Journal · doi:10.1042/bj20050960 · Cited by 53
c-Myc Sensitization to Oxygen Deprivation-induced Cell Death Is Dependent on Bax/Bak, but Is Independent of p53 and Hypoxia-inducible Factor-1
Brunelle, J. K., Santore, M. T., Budinger, G. R. S., Tang, Y., Barrett, T. A., Zong, W., Kandel, E., Keith, B., Simon, M. C., Thompson, C. B., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312241200 · Cited by 54
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Nicholson, S. A., Okby, N. T., Ma, K., Welsh, J. A., McMenamin, M. G., Travis, W. D., Jett, J. R., Tazelaar, H. D., Trastek, V. F., Pairolero, P. C., et al. (2001) · PubMed · Cited by 53
Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse
Khoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52
Differential Effects on ARF Stability by Normal versus Oncogenic Levels of c-Myc Expression
Chen, D., Kon, N., Zhong, J., Zhang, P., Yu, L., & Gu, W. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.006 · Cited by 55
The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase I
Li, Y., Rogulski, K. R., Zhou, Q., Sims, P. J., & Prochownik, E. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3401-3413.2006 · Cited by 52
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
Adams, C. M., Hiebert, S. W., & Eischen, C. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1751 · Cited by 52
Self-citation
Dual Role of the Alternative Reading Frame ARF Protein in Cancer
Fontana, R., Ranieri, M., Mantia, G. L., & Vivo, M. (2019) · Biomolecules · doi:10.3390/biom9030087 · Cited by 54
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer
Revia, S., Seretny, A., Wendler, L., Banito, A., Eckert, C., Breuer, K., Mayakonda, A., Lutsik, P., Evert, M., Ribback, S., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325405 · Cited by 52
Functions of Myc:Max in the Control of Cell Proliferation and Tumorigenesis
Hurlin, P. J., & Dezfouli, S. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)38004-6 · Cited by 54
Expression of the c‐myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer
Iba, T., Kigawa, J., Kanamori, Y., Itamochi, H., Oishi, T., SHIMADA, M., Uegaki, K., Naniwa, J., & Terakawa, N. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03225.x · Cited by 52
Arf‐dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye
Silva, R. L. A., Thornton, J. D., Martin, A. C., Rehg, J. E., Bertwistle, D., Zindy, F., & Skapek, S. X. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600751 · Cited by 54
Self-citation
v-Src Generates a p53-Independent Apoptotic Signal
Webb, B. L., Jimenez, E., & Martin, G. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9271-9280.2000 · Cited by 53
Tipping the Balance: Cdk2 Enables Myc to Suppress Senescence
Hydbring, P., & Larsson, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1383 · Cited by 52
BCL-W has a fundamental role in B cell survival and lymphomagenesis
Adams, C. M., Kim, A. S., Mitra, R., Choi, J. K., Gong, J. Z., & Eischen, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89486 · Cited by 51
Self-citation
A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis
Yu, D., & Thomas‐Tikhonenko, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205244 · Cited by 52
Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells
Kwok, W. K., Ling, M. T., Yuen, H., Wong, Y. C., & Wang, X. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm185 · Cited by 56
Human tumor suppressor ARF impedes S-phase progression independent of p53.
Yarbrough, W. G., Bessho, M., Zanation, A. M., Bisi, J., & Xiong, Y. (2002) · PubMed · Cited by 51
B23 and ARF: Friends or Foes?
Lindström, M. S., & Zhang, Y. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:46:1:79 · Cited by 52
The Myc-Nucleophosmin-ARF network: A complex web unveiled
Li, Z., & Hann, S. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9418 · Cited by 50
Regulation of CLU Gene Expression by Oncogenes and Epigenetic Factors
Sala, A., Bettuzzi, S., Pucci, S., Chayka, O., Dews, M., & Thomas‐Tikhonenko, A. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)05007-6 · Cited by 51
Aberrant expression of p16INK4a in human cancers – a new biomarker?
Inoue, K., & Fry, E. A. (2018) · Cancer Reports and Reviews · doi:10.15761/crr.1000145 · Cited by 51
Regulatory Elements in the Immunoglobulin Heavy Chain Gene 3′-Enhancers Induce c-myc Deregulation and Lymphomagenesis in Murine B Cells
Wang, J., & Boxer, L. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412446200 · Cited by 50
One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus
Gilley, J., & Fried, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204933 · Cited by 50
Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
Silva, J., Domínguez, G., Silva, J. M., García, J. M., Gallego, I., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204617 · Cited by 50
The Interferon- and Differentiation-inducible p202a Protein Inhibits the Transcriptional Activity of c-Myc by Blocking Its Association with Max
Wang, H., Liu, C.-J., Lu, Y., Chatterjee, G., Ma, X., Eisenman, R. N., & Lengyel, P. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61521-8 · Cited by 50
Molecular and genetic bases of neuroblastoma
Kamijo, T., & Nakagawara, A. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0415-7 · Cited by 51
Self-citation
Therapeutic Targets in the ARF Tumor Suppressor Pathway
Saporita, A. J., Maggi, L. B., Apicelli, A. J., & Weber, J. D. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058869 · Cited by 49
Bcl-xL gain of function and p19ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms
Finch, A. J., Prescott, J. E., Shchors, K., Hunt, A. E., Soucek, L., Dansen, T. B., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.017 · Cited by 49
Complexity in cancer biology: is systems biology the answer?
Koutsogiannouli, E. A., Papavassiliou, A. G., & Papanikolaou, N. A. (2013) · Cancer Medicine · doi:10.1002/cam4.62 · Cited by 51
New approaches for modelling cancer mechanisms in the mouse
Maddison, K., & Clarke, A. R. (2005) · The Journal of Pathology · doi:10.1002/path.1698 · Cited by 49
Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts
Kozawa, O., Tokuda, H., Matsuno, H., & Uematsu, T. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990901)74:3 · Cited by 48
Viruses and Lymphomas
Pagano, J. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmp020056 · Cited by 49
Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
Moore, L., Venkatachalam, S., Vogel, H., Watt, J. C., Wu, C.-L., Steinman, H., Jones, S. N., & Donehower, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206985 · Cited by 48
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 51
MEF immortalization to investigate the ins and outs of mutagenesis
Brocke, J. V., Schmeiser, H. H., Reinbold, M., & Hollstein, M. C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl101 · Cited by 51
Immortalization of mouse myogenic cells can occur without loss of p16 INK4a , p19 ARF , or p53 and is accelerated by inactivation of Bax
Nowak, J. A., Malowitz, J., Girgenrath, M., Kostek, C. A., Kravetz, A. J., Dominov, J. A., & Miller, J. B. (2004) · BMC Cell Biology · doi:10.1186/1471-2121-5-1 · Cited by 48
The DNA damage signal for Mdm2 regulation, Trp53 induction, and sunburn cell formation in vivo originates from actively transcribed genes
Brash, D. E., Wikonkal, N. M., Remenyik, E., van der Horst, G. T. J., Friedberg, E. C., Cheo, D. L., van Steeg, H., Westerman, A., & van Kranen, H. J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01554.x · Cited by 47
Tilting MYC toward cancer cell death
Harrington, C. T., Sotillo, E., Dang, C. V., & Thomas‐Tikhonenko, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.08.002 · Cited by 48
Control of Cell Proliferation and Growth by Myc Proteins
Bernard, S., & Eilers, M. (2006) · Springer eBooks · doi:10.1007/400_004 · Cited by 48
Expression of the HPV E7 Oncoprotein Mimics but Does Not Evoke a p53-Dependent Cellular DNA Damage Response Pathway
Jones, D. L., Thompson, D. A., Suh‐Burgmann, E., Grace, M. R., & Münger, K. (1999) · Virology · doi:10.1006/viro.1999.9733 · Cited by 47
Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision
Grieco, L., Calzone, L., Bernard‐Pierrot, I., Radvanyi, F., Kahn‐Perlès, B., & Thieffry, D. (2013) · PLoS Computational Biology · doi:10.1371/annotation/90e5e4be-952b-42b8-b56d-46baae3479ed · Cited by 47
The Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis
Dannenberg, J.-H., & te Riele, H. P. J. (2006) · Results and Problems in Cell Differentiation · doi:10.1007/400_002 · Cited by 47

Authors: Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Eischen, Christine M.
Kamijo, Takehiko
Cleveland, John L.
Sherr, Charles J.
Roussel, Martine F.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 1998-08-01
Volume: 12
Issue: 15
Pages: 2424-2433
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.12.15.2424
PMC: PMC317045
OpenAlex: W2046958356
Cited by: 1,245
References: 60
Citations by year: 2026: 6 · 2025: 15 · 2024: 14 · 2023: 32 · 2022: 10 · 2021: 27 · 2020: 15 · 2019: 22 · 2018: 15 · 2017: 23 · 2016: 28 · 2015: 19 · 2014: 43 · 2013: 45 · 2012: 46
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Institutes of Health (5r01ca056819-08, CA21765))
National Cancer Institute (CA-71907, CA56819, P30CA021765, P01CA071907)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 44158, R01DK044158)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: MYC signaling, ARF tumor suppressor, p53, apoptosis, cell immortalization, p19ARF, TP53 mutation, oncogenic transformation
MeSH terms: Animals, Cell Division, Cell Line, Humans, Models, Biological, Mutation, Proteins, Signal Transduction, Gene Expression, Genes, Tumor Suppressor, Genes, p53, Genes, myc, Apoptosis, Gene Deletion, Tumor Suppressor Protein p14ARF, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks